Thomas S. Robison is an accomplished inventor based in Saint Paul, MN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of dry powder inhalers. With a total of three patents to his name, Robison's work has the potential to enhance the delivery of biologically active substances.

Latest Patents

Robison's latest patents focus on dry powder inhalers. The disclosures describe powder inhalers and dry powder inhaler storage cassettes that include a compartment housing an elongate carrier preloaded with a plurality of doses of finely divided powder comprising a biologically active substance. The compartment is designed to seal the preloaded doses within it, allowing the carrier to be advanced from the compartment to the chamber through an exit equipped with a moisture barrier sealing system. This sealing system is configured to be relaxable during the advancement of the carrier. It remains in a sealing configuration prior to the advancement, relaxes upon the advancement, and returns to its sealing configuration after the release of the powder associated with the area of the carrier.

Career Highlights

Robison is currently associated with Adamis Pharmaceuticals Corporation, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing technologies that improve patient outcomes through more effective drug delivery systems.

Collaborations

Throughout his career, Robison has collaborated with notable colleagues, including Peter D. Hodson and Stephen W. Stein. These collaborations have contributed to the advancement of his inventions and the overall success of the projects he has been involved in.

Conclusion

Thomas S. Robison's contributions to the field of pharmaceuticals, particularly through his innovations in dry powder inhalers, demonstrate his commitment to improving healthcare solutions. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.